Comparison of gastrojejunostomy to endoscopic stenting for gastric outlet obstruction : An updated Systematic Review and Meta-analysis
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved..
BACKGROUND: This study aimed to determine the optimal intervention modality for malignant GOO by comparing clinical outcomes after Gastrojejunostomy and endoscopic stenting.
METHODS: Two authors independently searched Web of Science, PubMed, Embase, and the Cochrane Library for articles before February 2021 to compare the clinical outcomes of GOO patients undergoing GJ or ES.
RESULTS: This meta-analysis included 31 articles with 2444 GOO patients. Although the GJ group outperformed the ES group in technical success (OR,3.79; P = 0.003), clinical success was not significantly different between the two groups (OR,1.25; P = 0.50). The GJ group had a longer hospitalization, lower re-obstruction and lower reintervention. Moreover, GJ had a better survival than ES in the gastric cancer group (HR, 0.33; P = 0.009). However, no significant statistical difference was observed in the pancreatic cancer group (HR, 0.55; P = 0.159).
CONCLUSIONS: Both GJ and ES are safe and effective intervention modalities for malignant GOO. GJ had significantly improved survival in gastric cancer patients with GOO, while no significant difference was observed between the two groups in pancreatic cancer patients with GOO.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:223 |
|---|---|
| Enthalten in: |
American journal of surgery - 223(2022), 6 vom: 24. Juni, Seite 1067-1078 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hong, Jiaze [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Endoscopic stenting |
|---|
| Anmerkungen: |
Date Completed 27.06.2022 Date Revised 13.12.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.amjsurg.2021.10.038 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM33266242X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM33266242X | ||
| 003 | DE-627 | ||
| 005 | 20231227130624.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.amjsurg.2021.10.038 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1224.xml |
| 035 | |a (DE-627)NLM33266242X | ||
| 035 | |a (NLM)34728070 | ||
| 035 | |a (PII)S0002-9610(21)00629-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hong, Jiaze |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comparison of gastrojejunostomy to endoscopic stenting for gastric outlet obstruction |b An updated Systematic Review and Meta-analysis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.06.2022 | ||
| 500 | |a Date Revised 13.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: This study aimed to determine the optimal intervention modality for malignant GOO by comparing clinical outcomes after Gastrojejunostomy and endoscopic stenting | ||
| 520 | |a METHODS: Two authors independently searched Web of Science, PubMed, Embase, and the Cochrane Library for articles before February 2021 to compare the clinical outcomes of GOO patients undergoing GJ or ES | ||
| 520 | |a RESULTS: This meta-analysis included 31 articles with 2444 GOO patients. Although the GJ group outperformed the ES group in technical success (OR,3.79; P = 0.003), clinical success was not significantly different between the two groups (OR,1.25; P = 0.50). The GJ group had a longer hospitalization, lower re-obstruction and lower reintervention. Moreover, GJ had a better survival than ES in the gastric cancer group (HR, 0.33; P = 0.009). However, no significant statistical difference was observed in the pancreatic cancer group (HR, 0.55; P = 0.159) | ||
| 520 | |a CONCLUSIONS: Both GJ and ES are safe and effective intervention modalities for malignant GOO. GJ had significantly improved survival in gastric cancer patients with GOO, while no significant difference was observed between the two groups in pancreatic cancer patients with GOO | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Meta-Analysis | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a Endoscopic stenting | |
| 650 | 4 | |a Gastric outlet obstruction | |
| 650 | 4 | |a Gastrojejunostomy | |
| 650 | 4 | |a meta-Analysis | |
| 700 | 1 | |a Chen, Yizhou |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Jiayu |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Peidong |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Ping |e verfasserin |4 aut | |
| 700 | 1 | |a Du, Nannan |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Tongmin |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Jingjie |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of surgery |d 1945 |g 223(2022), 6 vom: 24. Juni, Seite 1067-1078 |w (DE-627)NLM000025658 |x 1879-1883 |7 nnns |
| 773 | 1 | 8 | |g volume:223 |g year:2022 |g number:6 |g day:24 |g month:06 |g pages:1067-1078 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.amjsurg.2021.10.038 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 223 |j 2022 |e 6 |b 24 |c 06 |h 1067-1078 | ||